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FAST TRACK
  Evidence-based answer
Signifi cantly. Patients with coronary heart 
disease (CHD) who refrain from smoking 
over a 2-year follow-up period decrease 
their relative risk (RR) for morbidity and 
mortality by about one third (strength of 
recommendation [SOR]: A, meta-analysis 
of 20 cohort studies). People who maintain 
abstinence after coronary artery bypass 
surgery are more likely to avoid angina, 
repeat revascularization, signifi cant 
physical impairment, and CHD-related 
hospital admissions than patients who 
continue to smoke (SOR: A, 4 cohort 
studies with 1- to 20-year follow-up).
How much does smoking 
cessation cut CHD risk?
❚ Evidence summary
The infl uence of cigarette smoking on 
the development of CHD has been well 
documented.1,2 RR ranges from 1.5 to 3, 
depending on variables such as age, sex, 
and quantity of tobacco used.3 Quitting 
smoking reduces overall mortality more 
than other forms of secondary preven-
tion, including aspirin, β-blockers, an-
giotensin-converting enzyme inhibitors, 
and cholesterol-lowering statins.3 In the 
wake of such evidence-based fi ndings, the 
American Heart Association and Ameri-
can College of Cardiology Task Force de-
veloped clinical practice guidelines that 
recommend complete smoking cessation 
for secondary prevention of CHD in car-
diac patients.4 
0 cigarettes = lower mortality 
and morbidity
A Cochrane Heart Group meta-analysis 
examining all-cause CHD mortality in 
20 cohort studies (n=12,603 patients), 
found a 36% reduction in mortality 
risk for CHD patients who quit smok-
ing compared with those who didn’t 
(RR=0.64; 95% confi dence interval 
[CI], 0.58-0.71).3 The review also noted 
a reduction in risk for nonfatal myocar-
dial infarctions (RR=0.68; 95% CI, 0.57-
0.82).3 The authors didn’t report how 
soon after smoking cessation mortality 
risk declined. 
The authors acknowledge several lim-
itations of the review, including the use of 
observational data and crude estimates, 
as well as potential publication bias and 
the misclassifi cation of smoking status. 
Notably, however, their fi ndings are con-
sistent with the landmark prospective, 
community-based cohort Framingham 
Heart Study (N=1422), which indicates 
that smoking status predicts overall and 
morbidity-free survival at age 85.5 
Smoking cessation has also been 
found to signifi cantly affect morbidity 
among cardiac patients. Short-term ben-
efi ts have been demonstrated in CHD 
patients after a myocardial infarction 
or coronary artery revascularization.6 
Smoking status at 1-year follow-up 
was associated with a signifi cant re-
duction in subsequent cardiac events 
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Patients with CHD 
who refrain from 
smoking for at 
least 2 years 
decrease their risk 
for morbidity 
and mortality by 
about one third
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(myocardial infarction, ischemic cere-
brovascular event, revascularization, or 
death from CHD) when smokers who 
quit after an initial CHD event were com-
pared with continuing smokers (odds ra-
tio=0.71; 95% CI, 0.38-1.33).6 
Going the distance is worth it
Regarding the role of extended absti-
nence on subsequent cardiac events, 
long-term quit status in post-coronary 
artery bypass graft (CABG) surgery 
patients has been found to predict de-
creased morbidity and lower rates of 
repeat revascularization surgery. Find-
ings from the Coronary Artery Surgery 
Study show that, at 10-year follow-up, 
nonsmokers were more likely to be free 
of angina (54% of nonsmokers vs 42% 
of smokers; P=.02, NNT=8.3) and less 
likely to experience moderate to se-
vere physical limitations (13% of non-
smokers vs 24% of smokers; P=.0004; 
NNT=9.1). Nonsmokers also had fewer 
CHD-related admissions than smokers 
(2.6 vs 3.8; P<.0001).7 
Another study found similar results 
at 20-year follow-up: Patients who had 
quit smoking underwent fewer repeat 
CABGs than smokers (RR=1.41; 95% 
CI, 1.02-1.94).8 The difference between 
post-CABG survival curves for quitters 
versus smokers increased from 3% at 
5 years (98% vs 95%) to 15% at 15 years 
(70% vs 55%; P<.0001; NNT=6.7).8
Recommendations
The US Department of Health and Hu-
man Services recommends smoking ces-
sation as an integral part of both primary 
and secondary prevention of CHD. Quit-
ting reduces development of atheroscle-
rosis and lowers the incidence of initial 
and recurrent myocardial infarction, 
thrombosis, cardiac arrhythmia, and 
death from cardiovascular causes.2 ■
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Quitting smoking 
reduces overall 
mortality more than 
other secondary 
prevention 
measures, 
including aspirin, 
β-blockers, 
ACE inhibitors, 
and statins
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and let us know what you think. 
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